Vertex Pharmaceuticals
Boston · Founded 1989
About Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.
Company Facts
- Founded: 1989
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $10M+
- Total funding: $657.3M
- Funding stage: IPO
- Last round: Post-IPO Secondary (Jul 2024)
- Ticker: nasdaq:VRTX
- Website: vrtx.com
- Phone: 617-341-6100
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vertex-pharmaceuticals-40664 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.